

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 4.96649725 |
| 2 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.96311888 |
| 3 | protein carboxylation (GO:0018214) | 4.96311888 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 4.67297536 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.67297536 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.63864132 |
| 7 | low-density lipoprotein particle clearance (GO:0034383) | 4.51552017 |
| 8 | kynurenine metabolic process (GO:0070189) | 4.47402752 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.45174595 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.45174595 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.38445735 |
| 12 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.37769568 |
| 13 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.37769568 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.36919779 |
| 15 | * high-density lipoprotein particle remodeling (GO:0034375) | 4.31366460 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.30730243 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.30730243 |
| 18 | regulation of fibrinolysis (GO:0051917) | 4.27711985 |
| 19 | defense response to fungus (GO:0050832) | 4.25429112 |
| 20 | plasma lipoprotein particle clearance (GO:0034381) | 4.19427056 |
| 21 | urea metabolic process (GO:0019627) | 4.18857507 |
| 22 | urea cycle (GO:0000050) | 4.18857507 |
| 23 | regulation of protein activation cascade (GO:2000257) | 4.18437840 |
| 24 | complement activation, alternative pathway (GO:0006957) | 4.14654020 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 4.10842627 |
| 26 | indole-containing compound catabolic process (GO:0042436) | 4.07672258 |
| 27 | indolalkylamine catabolic process (GO:0046218) | 4.07672258 |
| 28 | tryptophan catabolic process (GO:0006569) | 4.07672258 |
| 29 | regulation of complement activation (GO:0030449) | 4.02846435 |
| 30 | limb bud formation (GO:0060174) | 3.93366860 |
| 31 | ethanol oxidation (GO:0006069) | 3.91688106 |
| 32 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.90706889 |
| 33 | negative regulation of sterol transport (GO:0032372) | 3.86573372 |
| 34 | negative regulation of cholesterol transport (GO:0032375) | 3.86573372 |
| 35 | bile acid biosynthetic process (GO:0006699) | 3.83831221 |
| 36 | tryptophan metabolic process (GO:0006568) | 3.82519428 |
| 37 | homocysteine metabolic process (GO:0050667) | 3.79491818 |
| 38 | exogenous drug catabolic process (GO:0042738) | 3.79211954 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 3.78204623 |
| 40 | * reverse cholesterol transport (GO:0043691) | 3.76347766 |
| 41 | killing of cells of other organism (GO:0031640) | 3.73190055 |
| 42 | disruption of cells of other organism (GO:0044364) | 3.73190055 |
| 43 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.69521067 |
| 44 | nitrogen cycle metabolic process (GO:0071941) | 3.68885770 |
| 45 | neuronal stem cell maintenance (GO:0097150) | 3.66401413 |
| 46 | glyoxylate metabolic process (GO:0046487) | 3.65126129 |
| 47 | cysteine metabolic process (GO:0006534) | 3.62587506 |
| 48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.61180678 |
| 49 | sequestering of metal ion (GO:0051238) | 3.61126560 |
| 50 | presynaptic membrane assembly (GO:0097105) | 3.60002392 |
| 51 | phospholipid efflux (GO:0033700) | 3.59324830 |
| 52 | regulation of cholesterol homeostasis (GO:2000188) | 3.58897813 |
| 53 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.52586589 |
| 54 | response to fungus (GO:0009620) | 3.51291977 |
| 55 | cholesterol efflux (GO:0033344) | 3.51199645 |
| 56 | epoxygenase P450 pathway (GO:0019373) | 3.50545335 |
| 57 | hemidesmosome assembly (GO:0031581) | 3.48030638 |
| 58 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.46710184 |
| 59 | pentose-phosphate shunt (GO:0006098) | 3.46289199 |
| 60 | * plasma lipoprotein particle remodeling (GO:0034369) | 3.44785415 |
| 61 | * protein-lipid complex remodeling (GO:0034368) | 3.44785415 |
| 62 | * macromolecular complex remodeling (GO:0034367) | 3.44785415 |
| 63 | thyroid hormone generation (GO:0006590) | 3.44063748 |
| 64 | chronic inflammatory response (GO:0002544) | 3.43587185 |
| 65 | progesterone metabolic process (GO:0042448) | 3.43490983 |
| 66 | NADPH regeneration (GO:0006740) | 3.43055623 |
| 67 | thyroid hormone metabolic process (GO:0042403) | 3.42990789 |
| 68 | 4-hydroxyproline metabolic process (GO:0019471) | 3.41047857 |
| 69 | plasma lipoprotein particle assembly (GO:0034377) | 3.40822869 |
| 70 | presynaptic membrane organization (GO:0097090) | 3.40614867 |
| 71 | primary alcohol catabolic process (GO:0034310) | 3.40461649 |
| 72 | benzene-containing compound metabolic process (GO:0042537) | 3.40041676 |
| 73 | negative regulation of astrocyte differentiation (GO:0048712) | 3.38870402 |
| 74 | bile acid metabolic process (GO:0008206) | 3.37458916 |
| 75 | ethanol metabolic process (GO:0006067) | 3.34252840 |
| 76 | protein-lipid complex assembly (GO:0065005) | 3.32259641 |
| 77 | amino-acid betaine metabolic process (GO:0006577) | 3.31956210 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 3.22719976 |
| 79 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.22462124 |
| 80 | behavioral response to nicotine (GO:0035095) | 3.21470758 |
| 81 | positive regulation of lipid catabolic process (GO:0050996) | 3.19599277 |
| 82 | drug catabolic process (GO:0042737) | 3.18888960 |
| 83 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.18445553 |
| 84 | fibrinolysis (GO:0042730) | 3.18433187 |
| 85 | regulation of hippo signaling (GO:0035330) | 3.16163324 |
| 86 | regulation of cholesterol esterification (GO:0010872) | 3.15029532 |
| 87 | lysine catabolic process (GO:0006554) | 3.12685796 |
| 88 | lysine metabolic process (GO:0006553) | 3.12685796 |
| 89 | cell proliferation in forebrain (GO:0021846) | 3.11321539 |
| 90 | acylglycerol homeostasis (GO:0055090) | 3.10528051 |
| 91 | triglyceride homeostasis (GO:0070328) | 3.10528051 |
| 92 | postsynaptic membrane organization (GO:0001941) | 3.09656377 |
| 93 | cellular glucuronidation (GO:0052695) | 3.09556127 |
| 94 | * phospholipid homeostasis (GO:0055091) | 3.09113950 |
| 95 | regulation of cholesterol storage (GO:0010885) | 3.08812646 |
| 96 | * cholesterol homeostasis (GO:0042632) | 3.08551499 |
| 97 | NADP metabolic process (GO:0006739) | 3.07357438 |
| 98 | lymphangiogenesis (GO:0001946) | 3.07241181 |
| 99 | * sterol homeostasis (GO:0055092) | 3.06364379 |
| 100 | lateral sprouting from an epithelium (GO:0060601) | 3.05407374 |
| 101 | artery development (GO:0060840) | 3.03515782 |
| 102 | positive regulation of blood coagulation (GO:0030194) | 3.01677950 |
| 103 | positive regulation of hemostasis (GO:1900048) | 3.01677950 |
| 104 | oxidative demethylation (GO:0070989) | 3.01029172 |
| 105 | aromatic amino acid family metabolic process (GO:0009072) | 3.00603376 |
| 106 | cellular response to cholesterol (GO:0071397) | 3.00395419 |
| 107 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.99874902 |
| 108 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.99619489 |
| 109 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.99034927 |
| 110 | cellular response to sterol (GO:0036315) | 2.98994784 |
| 111 | serine family amino acid biosynthetic process (GO:0009070) | 2.98507117 |
| 112 | nephron tubule formation (GO:0072079) | 2.98365609 |
| 113 | serine family amino acid catabolic process (GO:0009071) | 2.97605143 |
| 114 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.96051171 |
| 115 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.96051171 |
| 116 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.95667466 |
| 117 | bile acid and bile salt transport (GO:0015721) | 2.95412694 |
| 118 | * plasma lipoprotein particle organization (GO:0071827) | 2.93146082 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.92480266 |
| 120 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.92437186 |
| 121 | leukocyte aggregation (GO:0070486) | 2.92174413 |
| 122 | * protein-lipid complex subunit organization (GO:0071825) | 2.91186597 |
| 123 | negative regulation of protein activation cascade (GO:2000258) | 2.89808955 |
| 124 | flavonoid metabolic process (GO:0009812) | 2.89572596 |
| 125 | protein activation cascade (GO:0072376) | 2.88353217 |
| 126 | positive regulation of coagulation (GO:0050820) | 2.88105538 |
| 127 | cellular ketone body metabolic process (GO:0046950) | 2.87090960 |
| 128 | omega-hydroxylase P450 pathway (GO:0097267) | 2.86245033 |
| 129 | negative regulation of axon guidance (GO:1902668) | 2.78737169 |
| 130 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.77188835 |
| 131 | otic vesicle formation (GO:0030916) | 2.75347113 |
| 132 | nucleobase catabolic process (GO:0046113) | 2.73075712 |
| 133 | regulation of keratinocyte proliferation (GO:0010837) | 2.71746495 |
| 134 | neural crest cell development (GO:0014032) | 2.70698454 |
| 135 | auditory receptor cell differentiation (GO:0042491) | 2.69972735 |
| 136 | phasic smooth muscle contraction (GO:0014821) | 2.69774116 |
| 137 | heart valve formation (GO:0003188) | 2.69630806 |
| 138 | retinal ganglion cell axon guidance (GO:0031290) | 2.65561514 |
| 139 | nonmotile primary cilium assembly (GO:0035058) | 2.62026683 |
| 140 | arginine catabolic process (GO:0006527) | 2.59991239 |
| 141 | L-fucose catabolic process (GO:0042355) | 2.59077317 |
| 142 | fucose catabolic process (GO:0019317) | 2.59077317 |
| 143 | L-fucose metabolic process (GO:0042354) | 2.59077317 |
| 144 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.58472457 |
| 145 | kidney morphogenesis (GO:0060993) | 2.58354342 |
| 146 | neuron fate determination (GO:0048664) | 2.57808690 |
| 147 | negative chemotaxis (GO:0050919) | 2.55535338 |
| 148 | Notch signaling involved in heart development (GO:0061314) | 2.55497445 |
| 149 | ketone body metabolic process (GO:1902224) | 2.54096817 |
| 150 | limb development (GO:0060173) | 2.53984348 |
| 151 | appendage development (GO:0048736) | 2.53984348 |
| 152 | axon ensheathment in central nervous system (GO:0032291) | 2.52648618 |
| 153 | central nervous system myelination (GO:0022010) | 2.52648618 |
| 154 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.50594989 |
| 155 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.50581471 |
| 156 | negative regulation of lipase activity (GO:0060192) | 2.50427213 |
| 157 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.48511268 |
| 158 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.47224156 |
| 159 | indolalkylamine metabolic process (GO:0006586) | 2.46713286 |
| 160 | negative regulation of glial cell differentiation (GO:0045686) | 2.46290471 |
| 161 | tongue development (GO:0043586) | 2.44230677 |
| 162 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.44161080 |
| 163 | sulfation (GO:0051923) | 2.42963795 |
| 164 | signal peptide processing (GO:0006465) | 2.42377512 |
| 165 | reflex (GO:0060004) | 2.40828913 |
| 166 | response to pheromone (GO:0019236) | 2.38977887 |
| 167 | regulation of astrocyte differentiation (GO:0048710) | 2.38933950 |
| 168 | regulation of axon guidance (GO:1902667) | 2.37173510 |
| 169 | gamma-aminobutyric acid transport (GO:0015812) | 2.35905145 |
| 170 | nephron epithelium morphogenesis (GO:0072088) | 2.33288226 |
| 171 | nephron tubule morphogenesis (GO:0072078) | 2.33288226 |
| 172 | regulation of mesoderm development (GO:2000380) | 2.32582968 |
| 173 | arginine metabolic process (GO:0006525) | 2.30972530 |
| 174 | pattern specification involved in kidney development (GO:0061004) | 2.30917413 |
| 175 | inner ear receptor stereocilium organization (GO:0060122) | 2.30432080 |
| 176 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.30110001 |
| 177 | dorsal/ventral axis specification (GO:0009950) | 2.25376520 |
| 178 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.25130762 |
| 179 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.23828280 |
| 180 | stem cell development (GO:0048864) | 2.23639331 |
| 181 | platelet dense granule organization (GO:0060155) | 2.22379871 |
| 182 | renal tubule morphogenesis (GO:0061333) | 2.20574642 |
| 183 | cochlea development (GO:0090102) | 2.20435109 |
| 184 | mechanoreceptor differentiation (GO:0042490) | 2.20298006 |
| 185 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.20033354 |
| 186 | inner ear receptor cell differentiation (GO:0060113) | 2.19457563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.77916941 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.52273984 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.00839791 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.56322452 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.48557104 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.72674128 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.24908283 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.17401595 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.17316028 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.14455768 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.01666923 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.74966576 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.74181122 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.67219853 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.63100482 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.60531958 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.59962253 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.51401036 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.43658826 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40489945 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40130292 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.37011639 |
| 23 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.34469010 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.33478129 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25005110 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.13423204 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.12746246 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.03483742 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.01160022 |
| 30 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.99492991 |
| 31 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.98503294 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.97467749 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.97011195 |
| 34 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.95601779 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.93838210 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.92315021 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90772437 |
| 38 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78276906 |
| 39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.77962209 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.75359189 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74795243 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73010126 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70683484 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.69826206 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.68206420 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.67666650 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.65760151 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.65228413 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65159400 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.64869358 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64838500 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62761285 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.60021684 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.59403594 |
| 55 | FUS_26573619_Chip-Seq_HEK293_Human | 1.58063733 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.56297280 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.55257845 |
| 58 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.54684539 |
| 59 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.53737699 |
| 60 | AR_25329375_ChIP-Seq_VCAP_Human | 1.53723392 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.52928519 |
| 62 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52189686 |
| 63 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.51309708 |
| 64 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50986563 |
| 65 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.50981861 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50908064 |
| 67 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49721408 |
| 68 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.49482778 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48126295 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47398015 |
| 71 | EWS_26573619_Chip-Seq_HEK293_Human | 1.46929227 |
| 72 | CJUN_26792858_Chip-Seq_BT549_Human | 1.44996821 |
| 73 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.44710451 |
| 74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.44626804 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43976115 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43741763 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43483930 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43079145 |
| 79 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.42732703 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.40435315 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40224869 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39686658 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39430558 |
| 84 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.38076740 |
| 85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37929522 |
| 86 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.37517950 |
| 87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32731031 |
| 88 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.31847314 |
| 89 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.31699540 |
| 90 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.31699540 |
| 91 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31512108 |
| 92 | TCF4_23295773_ChIP-Seq_U87_Human | 1.30105200 |
| 93 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.29378200 |
| 94 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29021186 |
| 95 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.28752007 |
| 96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28249455 |
| 97 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28120336 |
| 98 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.27638742 |
| 99 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27638742 |
| 100 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.27637434 |
| 101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26729664 |
| 102 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.26616450 |
| 103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25391117 |
| 104 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.25068771 |
| 105 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.24889690 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24422044 |
| 107 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.24269820 |
| 108 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23865997 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23675743 |
| 110 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22960149 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22097167 |
| 112 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.22049237 |
| 113 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21443922 |
| 114 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21185893 |
| 115 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.20660210 |
| 116 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19354760 |
| 117 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19133413 |
| 118 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.18772844 |
| 119 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.18700319 |
| 120 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18019937 |
| 121 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17391762 |
| 122 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.16935410 |
| 123 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14910218 |
| 124 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14827980 |
| 125 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14345786 |
| 126 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13919521 |
| 127 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.13796515 |
| 128 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13753751 |
| 129 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.13622306 |
| 130 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13417622 |
| 131 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.13215041 |
| 132 | MYC_22102868_ChIP-Seq_BL_Human | 1.12971524 |
| 133 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12545985 |
| 134 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12394776 |
| 135 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.12142859 |
| 136 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12122168 |
| 137 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.11415420 |
| 138 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.11265188 |
| 139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10972372 |
| 140 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10898276 |
| 141 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10622635 |
| 142 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10622635 |
| 143 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10512483 |
| 144 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10354157 |
| 145 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.10328553 |
| 146 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.09977364 |
| 147 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.09050861 |
| 148 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08850242 |
| 149 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08718190 |
| 150 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08603811 |
| 151 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.08277413 |
| 152 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.08083370 |
| 153 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07722956 |
| 154 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06273808 |
| 155 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05918833 |
| 156 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05743676 |
| 157 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05691923 |
| 158 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05675705 |
| 159 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04829842 |
| 160 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04063019 |
| 161 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03930381 |
| 162 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02084015 |
| 163 | MAF_26560356_Chip-Seq_TH1_Human | 1.00631333 |
| 164 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.00082785 |
| 165 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98974457 |
| 166 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98320068 |
| 167 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97772367 |
| 168 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96494448 |
| 169 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96332390 |
| 170 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96332390 |
| 171 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94930592 |
| 172 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93530700 |
| 173 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92968976 |
| 174 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91491283 |
| 175 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90883039 |
| 176 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.88764343 |
| 177 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88557706 |
| 178 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.88246084 |
| 179 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88008274 |
| 180 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87415751 |
| 181 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87004421 |
| 182 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86655714 |
| 183 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86378922 |
| 184 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85022754 |
| 185 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83133298 |
| 186 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82298323 |
| 187 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81917073 |
| 188 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81305243 |
| 189 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80580441 |
| 190 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79646303 |
| 191 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.79320512 |
| 192 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78626098 |
| 193 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78272111 |
| 194 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.77974654 |
| 195 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.77374413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.60788101 |
| 2 | MP0005360_urolithiasis | 5.30459464 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.96875296 |
| 4 | MP0005365_abnormal_bile_salt | 3.82034355 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.80446346 |
| 6 | MP0003136_yellow_coat_color | 3.31091124 |
| 7 | MP0009840_abnormal_foam_cell | 3.29690750 |
| 8 | MP0003303_peritoneal_inflammation | 3.17423667 |
| 9 | MP0000566_synostosis | 2.96894934 |
| 10 | MP0004885_abnormal_endolymph | 2.93414990 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.91329077 |
| 12 | * MP0010329_abnormal_lipoprotein_level | 2.66064385 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.44174011 |
| 14 | MP0000579_abnormal_nail_morphology | 2.29202746 |
| 15 | MP0000537_abnormal_urethra_morphology | 2.27838668 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.26778520 |
| 17 | MP0003252_abnormal_bile_duct | 2.24788653 |
| 18 | MP0005083_abnormal_biliary_tract | 2.23786332 |
| 19 | MP0003724_increased_susceptibility_to | 2.23144621 |
| 20 | MP0002234_abnormal_pharynx_morphology | 2.14083185 |
| 21 | MP0006292_abnormal_olfactory_placode | 2.13887496 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.11933865 |
| 23 | MP0000778_abnormal_nervous_system | 2.05832364 |
| 24 | MP0002876_abnormal_thyroid_physiology | 1.99081869 |
| 25 | MP0010368_abnormal_lymphatic_system | 1.85778645 |
| 26 | MP0003436_decreased_susceptibility_to | 1.80689276 |
| 27 | MP0001485_abnormal_pinna_reflex | 1.80093800 |
| 28 | MP0006054_spinal_hemorrhage | 1.80071612 |
| 29 | MP0000609_abnormal_liver_physiology | 1.78234274 |
| 30 | MP0002282_abnormal_trachea_morphology | 1.77238506 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.74137336 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.72891029 |
| 33 | MP0000569_abnormal_digit_pigmentation | 1.69849850 |
| 34 | MP0003890_abnormal_embryonic-extraembry | 1.67702737 |
| 35 | MP0002928_abnormal_bile_duct | 1.67166429 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.62636881 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.60668982 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.58936164 |
| 39 | MP0000762_abnormal_tongue_morphology | 1.57502721 |
| 40 | MP0004264_abnormal_extraembryonic_tissu | 1.57097953 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.55935884 |
| 42 | MP0004272_abnormal_basement_membrane | 1.54776425 |
| 43 | MP0005332_abnormal_amino_acid | 1.54461202 |
| 44 | MP0000049_abnormal_middle_ear | 1.53008906 |
| 45 | MP0005187_abnormal_penis_morphology | 1.51227011 |
| 46 | * MP0002118_abnormal_lipid_homeostasis | 1.47776254 |
| 47 | MP0000026_abnormal_inner_ear | 1.45704148 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.44622990 |
| 49 | MP0004947_skin_inflammation | 1.42872813 |
| 50 | MP0005023_abnormal_wound_healing | 1.42786725 |
| 51 | MP0003195_calcinosis | 1.40934228 |
| 52 | MP0004133_heterotaxia | 1.40569507 |
| 53 | MP0003755_abnormal_palate_morphology | 1.39861822 |
| 54 | MP0002254_reproductive_system_inflammat | 1.39255561 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.34967422 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.34836090 |
| 57 | MP0000604_amyloidosis | 1.32783110 |
| 58 | MP0005058_abnormal_lysosome_morphology | 1.31978372 |
| 59 | MP0003186_abnormal_redox_activity | 1.28787812 |
| 60 | MP0002419_abnormal_innate_immunity | 1.28077264 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.27947310 |
| 62 | MP0002938_white_spotting | 1.27920690 |
| 63 | MP0002653_abnormal_ependyma_morphology | 1.27738713 |
| 64 | MP0003878_abnormal_ear_physiology | 1.27633799 |
| 65 | MP0005377_hearing/vestibular/ear_phenot | 1.27633799 |
| 66 | MP0000343_altered_response_to | 1.26069247 |
| 67 | MP0003937_abnormal_limbs/digits/tail_de | 1.25728749 |
| 68 | MP0009764_decreased_sensitivity_to | 1.24106710 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.23746022 |
| 70 | MP0009278_abnormal_bone_marrow | 1.23737648 |
| 71 | MP0003119_abnormal_digestive_system | 1.21816403 |
| 72 | MP0000631_abnormal_neuroendocrine_gland | 1.21214412 |
| 73 | MP0001293_anophthalmia | 1.21068335 |
| 74 | MP0000427_abnormal_hair_cycle | 1.20165550 |
| 75 | MP0009785_altered_susceptibility_to | 1.18976342 |
| 76 | MP0005164_abnormal_response_to | 1.18332608 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 1.17579840 |
| 78 | MP0000598_abnormal_liver_morphology | 1.15442619 |
| 79 | MP0000538_abnormal_urinary_bladder | 1.14866949 |
| 80 | MP0000516_abnormal_urinary_system | 1.14155019 |
| 81 | MP0005367_renal/urinary_system_phenotyp | 1.14155019 |
| 82 | MP0006072_abnormal_retinal_apoptosis | 1.13285814 |
| 83 | MP0000467_abnormal_esophagus_morphology | 1.11100790 |
| 84 | MP0008469_abnormal_protein_level | 1.10301197 |
| 85 | MP0005076_abnormal_cell_differentiation | 1.10214052 |
| 86 | MP0009763_increased_sensitivity_to | 1.09492845 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08934840 |
| 88 | MP0001851_eye_inflammation | 1.08331434 |
| 89 | MP0005195_abnormal_posterior_eye | 1.07084866 |
| 90 | MP0001501_abnormal_sleep_pattern | 1.06789136 |
| 91 | MP0002697_abnormal_eye_size | 1.06556190 |
| 92 | MP0000613_abnormal_salivary_gland | 1.06509881 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 1.05123973 |
| 94 | MP0002233_abnormal_nose_morphology | 1.03964594 |
| 95 | MP0010234_abnormal_vibrissa_follicle | 1.03734044 |
| 96 | MP0009053_abnormal_anal_canal | 1.03627368 |
| 97 | MP0004270_analgesia | 1.02669659 |
| 98 | MP0005451_abnormal_body_composition | 1.02658290 |
| 99 | MP0001845_abnormal_inflammatory_respons | 1.00651317 |
| 100 | MP0001984_abnormal_olfaction | 1.00117471 |
| 101 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99706601 |
| 102 | MP0009643_abnormal_urine_homeostasis | 0.99293791 |
| 103 | MP0005253_abnormal_eye_physiology | 0.99000245 |
| 104 | MP0000465_gastrointestinal_hemorrhage | 0.98743439 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.98597785 |
| 106 | MP0004883_abnormal_blood_vessel | 0.98560746 |
| 107 | MP0002796_impaired_skin_barrier | 0.98277332 |
| 108 | MP0002098_abnormal_vibrissa_morphology | 0.98123626 |
| 109 | MP0004043_abnormal_pH_regulation | 0.97918359 |
| 110 | MP0004142_abnormal_muscle_tone | 0.97693933 |
| 111 | MP0003935_abnormal_craniofacial_develop | 0.97182933 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.96795847 |
| 113 | MP0000647_abnormal_sebaceous_gland | 0.96169905 |
| 114 | MP0003329_amyloid_beta_deposits | 0.95927089 |
| 115 | MP0002102_abnormal_ear_morphology | 0.95403573 |
| 116 | MP0008872_abnormal_physiological_respon | 0.94224799 |
| 117 | MP0001286_abnormal_eye_development | 0.94213510 |
| 118 | MP0002736_abnormal_nociception_after | 0.93350680 |
| 119 | MP0005025_abnormal_response_to | 0.91453489 |
| 120 | MP0005391_vision/eye_phenotype | 0.91152636 |
| 121 | MP0003011_delayed_dark_adaptation | 0.89872891 |
| 122 | MP0005171_absent_coat_pigmentation | 0.87871092 |
| 123 | MP0008789_abnormal_olfactory_epithelium | 0.87748745 |
| 124 | MP0001764_abnormal_homeostasis | 0.87521278 |
| 125 | MP0005595_abnormal_vascular_smooth | 0.87174886 |
| 126 | MP0003075_altered_response_to | 0.87151544 |
| 127 | MP0001963_abnormal_hearing_physiology | 0.86733992 |
| 128 | MP0003880_abnormal_central_pattern | 0.86015202 |
| 129 | MP0003283_abnormal_digestive_organ | 0.85593665 |
| 130 | MP0005670_abnormal_white_adipose | 0.83931648 |
| 131 | MP0001968_abnormal_touch/_nociception | 0.81749708 |
| 132 | MP0003718_maternal_effect | 0.81261634 |
| 133 | MP0005646_abnormal_pituitary_gland | 0.80537122 |
| 134 | MP0005167_abnormal_blood-brain_barrier | 0.80380895 |
| 135 | * MP0000249_abnormal_blood_vessel | 0.80372751 |
| 136 | MP0001486_abnormal_startle_reflex | 0.80355240 |
| 137 | MP0003315_abnormal_perineum_morphology | 0.80184012 |
| 138 | MP0000428_abnormal_craniofacial_morphol | 0.79852312 |
| 139 | MP0010155_abnormal_intestine_physiology | 0.79279223 |
| 140 | MP0003868_abnormal_feces_composition | 0.79200818 |
| 141 | MP0002092_abnormal_eye_morphology | 0.77705834 |
| 142 | MP0002572_abnormal_emotion/affect_behav | 0.77618338 |
| 143 | MP0008438_abnormal_cutaneous_collagen | 0.77598385 |
| 144 | MP0001879_abnormal_lymphatic_vessel | 0.77567328 |
| 145 | MP0002557_abnormal_social/conspecific_i | 0.77472476 |
| 146 | MP0006276_abnormal_autonomic_nervous | 0.77405876 |
| 147 | MP0001915_intracranial_hemorrhage | 0.73351523 |
| 148 | MP0003122_maternal_imprinting | 0.73000231 |
| 149 | MP0002184_abnormal_innervation | 0.72735137 |
| 150 | MP0008004_abnormal_stomach_pH | 0.72651139 |
| 151 | MP0000955_abnormal_spinal_cord | 0.72205234 |
| 152 | MP0002752_abnormal_somatic_nervous | 0.72003903 |
| 153 | MP0002060_abnormal_skin_morphology | 0.71401514 |
| 154 | MP0002751_abnormal_autonomic_nervous | 0.71079195 |
| 155 | MP0004742_abnormal_vestibular_system | 0.70982374 |
| 156 | MP0009250_abnormal_appendicular_skeleto | 0.70822638 |
| 157 | MP0000685_abnormal_immune_system | 0.70344741 |
| 158 | MP0004858_abnormal_nervous_system | 0.70324690 |
| 159 | MP0010030_abnormal_orbit_morphology | 0.70218739 |
| 160 | MP0001881_abnormal_mammary_gland | 0.69087837 |
| 161 | MP0001853_heart_inflammation | 0.68680601 |
| 162 | MP0003172_abnormal_lysosome_physiology | 0.68027219 |
| 163 | MP0009765_abnormal_xenobiotic_induced | 0.67028931 |
| 164 | MP0001216_abnormal_epidermal_layer | 0.66996486 |
| 165 | MP0002405_respiratory_system_inflammati | 0.66419797 |
| 166 | MP0009931_abnormal_skin_appearance | 0.66109905 |
| 167 | * MP0009642_abnormal_blood_homeostasis | 0.65807749 |
| 168 | MP0010678_abnormal_skin_adnexa | 0.65758836 |
| 169 | MP0006082_CNS_inflammation | 0.65598577 |
| 170 | MP0002136_abnormal_kidney_physiology | 0.64850903 |
| 171 | MP0003091_abnormal_cell_migration | 0.64651178 |
| 172 | MP0001243_abnormal_dermal_layer | 0.62656103 |
| 173 | MP0000767_abnormal_smooth_muscle | 0.61441520 |
| 174 | MP0000383_abnormal_hair_follicle | 0.61129351 |
| 175 | MP0005636_abnormal_mineral_homeostasis | 0.61002098 |
| 176 | MP0004185_abnormal_adipocyte_glucose | 0.60581788 |
| 177 | MP0001756_abnormal_urination | 0.60091750 |
| 178 | MP0004510_myositis | 0.58771178 |
| 179 | MP0000013_abnormal_adipose_tissue | 0.58448340 |
| 180 | MP0004130_abnormal_muscle_cell | 0.57779969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.08895406 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.58479900 |
| 3 | Xanthomatosis (HP:0000991) | 5.03893351 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.01562556 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.62587225 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.56587072 |
| 7 | Joint hemorrhage (HP:0005261) | 4.49821614 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.41455676 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.30577547 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.30113481 |
| 11 | True hermaphroditism (HP:0010459) | 3.82618468 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.77776461 |
| 13 | Complement deficiency (HP:0004431) | 3.75648072 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 3.75067166 |
| 15 | Epidermoid cyst (HP:0200040) | 3.57652169 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 3.47754451 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.39719072 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.29173121 |
| 19 | Pancreatic cysts (HP:0001737) | 3.28093667 |
| 20 | Menorrhagia (HP:0000132) | 3.27020756 |
| 21 | Myocardial infarction (HP:0001658) | 3.22071856 |
| 22 | Hyperventilation (HP:0002883) | 3.17002243 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.15937085 |
| 24 | Pancreatic fibrosis (HP:0100732) | 3.15366077 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.14872398 |
| 26 | Vascular calcification (HP:0004934) | 3.06682638 |
| 27 | Abnormality of complement system (HP:0005339) | 3.05266871 |
| 28 | Chorioretinal atrophy (HP:0000533) | 3.04968958 |
| 29 | Esophageal varix (HP:0002040) | 2.97876142 |
| 30 | Increased mean platelet volume (HP:0011877) | 2.92054863 |
| 31 | Abnormal platelet volume (HP:0011876) | 2.87183813 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 2.84548681 |
| 33 | Thyroid-stimulating hormone excess (HP:0002925) | 2.83402134 |
| 34 | Cardiovascular calcification (HP:0011915) | 2.83072413 |
| 35 | Abnormality of midbrain morphology (HP:0002418) | 2.82006423 |
| 36 | Molar tooth sign on MRI (HP:0002419) | 2.82006423 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.81487719 |
| 38 | Recurrent abscess formation (HP:0002722) | 2.81076541 |
| 39 | Neonatal short-limb short stature (HP:0008921) | 2.79700397 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.75949133 |
| 41 | Gingival bleeding (HP:0000225) | 2.69496104 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 2.67690201 |
| 43 | Hyperammonemia (HP:0001987) | 2.66450397 |
| 44 | Bronchomalacia (HP:0002780) | 2.59041836 |
| 45 | Nephronophthisis (HP:0000090) | 2.58995354 |
| 46 | Hypercholesterolemia (HP:0003124) | 2.57923952 |
| 47 | Hemiparesis (HP:0001269) | 2.57711961 |
| 48 | Gastrointestinal atresia (HP:0002589) | 2.57111810 |
| 49 | Nonimmune hydrops fetalis (HP:0001790) | 2.56716815 |
| 50 | Esophageal atresia (HP:0002032) | 2.56616751 |
| 51 | Osteolytic defects of the hand bones (HP:0009699) | 2.56384414 |
| 52 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.56384414 |
| 53 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.56191157 |
| 54 | Right ventricular cardiomyopathy (HP:0011663) | 2.55668769 |
| 55 | Abnormality of the renal medulla (HP:0100957) | 2.55360056 |
| 56 | Chronic hepatic failure (HP:0100626) | 2.55296061 |
| 57 | Keratoconus (HP:0000563) | 2.54378211 |
| 58 | Increased corneal curvature (HP:0100692) | 2.54378211 |
| 59 | Split foot (HP:0001839) | 2.47240677 |
| 60 | Milia (HP:0001056) | 2.42287973 |
| 61 | Peritonitis (HP:0002586) | 2.40779702 |
| 62 | Hypoglycemic coma (HP:0001325) | 2.40007572 |
| 63 | Spastic diplegia (HP:0001264) | 2.39509022 |
| 64 | Abnormality of the nasal septum (HP:0000419) | 2.38718469 |
| 65 | Type II lissencephaly (HP:0007260) | 2.38617068 |
| 66 | Fat malabsorption (HP:0002630) | 2.37074970 |
| 67 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.37002729 |
| 68 | Sclerocornea (HP:0000647) | 2.35101611 |
| 69 | Fragile nails (HP:0001808) | 2.34080889 |
| 70 | Abnormality of nucleobase metabolism (HP:0010932) | 2.33337233 |
| 71 | Ketosis (HP:0001946) | 2.33192622 |
| 72 | Abnormality of macrophages (HP:0004311) | 2.31598924 |
| 73 | Cutaneous finger syndactyly (HP:0010554) | 2.31548277 |
| 74 | Fair hair (HP:0002286) | 2.29232385 |
| 75 | Abnormality of the renal cortex (HP:0011035) | 2.29181969 |
| 76 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.23046872 |
| 77 | Pulmonary embolism (HP:0002204) | 2.22572681 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.21910271 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.21902435 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 2.20278256 |
| 81 | Progressive cerebellar ataxia (HP:0002073) | 2.20244316 |
| 82 | Cystic liver disease (HP:0006706) | 2.19570055 |
| 83 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.19324781 |
| 84 | Preaxial foot polydactyly (HP:0001841) | 2.17351047 |
| 85 | Hypoplastic labia majora (HP:0000059) | 2.17078823 |
| 86 | Congenital sensorineural hearing impairment (HP:0008527) | 2.15646162 |
| 87 | Polycythemia (HP:0001901) | 2.14513833 |
| 88 | Recurrent skin infections (HP:0001581) | 2.14498050 |
| 89 | Urticaria (HP:0001025) | 2.13994610 |
| 90 | Amyloidosis (HP:0011034) | 2.13801846 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.12987601 |
| 92 | Hydroxyprolinuria (HP:0003080) | 2.12987601 |
| 93 | Congenital stationary night blindness (HP:0007642) | 2.12302867 |
| 94 | Hypoplastic pelvis (HP:0008839) | 2.12241999 |
| 95 | Thrombophlebitis (HP:0004418) | 2.12056121 |
| 96 | Optic nerve hypoplasia (HP:0000609) | 2.11749154 |
| 97 | Purpura (HP:0000979) | 2.11623150 |
| 98 | Nephritis (HP:0000123) | 2.11070912 |
| 99 | Lymphangioma (HP:0100764) | 2.10774018 |
| 100 | Renal hypoplasia (HP:0000089) | 2.10760964 |
| 101 | Medial flaring of the eyebrow (HP:0010747) | 2.10747393 |
| 102 | Abnormal platelet function (HP:0011869) | 2.10372676 |
| 103 | Impaired platelet aggregation (HP:0003540) | 2.10372676 |
| 104 | Skin nodule (HP:0200036) | 2.10119782 |
| 105 | Anterior segment dysgenesis (HP:0007700) | 2.08123789 |
| 106 | Septo-optic dysplasia (HP:0100842) | 2.07747705 |
| 107 | Hepatocellular carcinoma (HP:0001402) | 2.06784074 |
| 108 | Atrophic scars (HP:0001075) | 2.05839568 |
| 109 | Oligodactyly (hands) (HP:0001180) | 2.05507050 |
| 110 | Tubular atrophy (HP:0000092) | 2.04499472 |
| 111 | Epistaxis (HP:0000421) | 2.03971409 |
| 112 | Ulnar bowing (HP:0003031) | 2.02211271 |
| 113 | Occipital encephalocele (HP:0002085) | 2.00351237 |
| 114 | Adactyly (HP:0009776) | 1.99805469 |
| 115 | Scrotal hypoplasia (HP:0000046) | 1.99639983 |
| 116 | Mitral stenosis (HP:0001718) | 1.98616103 |
| 117 | Fibular aplasia (HP:0002990) | 1.98408733 |
| 118 | Abnormality of the labia majora (HP:0012881) | 1.97457673 |
| 119 | Furrowed tongue (HP:0000221) | 1.95047245 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94840086 |
| 121 | Genital tract atresia (HP:0001827) | 1.93776829 |
| 122 | Short 4th metacarpal (HP:0010044) | 1.93205372 |
| 123 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.93205372 |
| 124 | Drooling (HP:0002307) | 1.93203204 |
| 125 | Goiter (HP:0000853) | 1.93134906 |
| 126 | Abnormality of glycine metabolism (HP:0010895) | 1.92803674 |
| 127 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.92803674 |
| 128 | Spontaneous hematomas (HP:0007420) | 1.92621679 |
| 129 | Coronal craniosynostosis (HP:0004440) | 1.91933108 |
| 130 | Genetic anticipation (HP:0003743) | 1.91593746 |
| 131 | Onycholysis (HP:0001806) | 1.91366190 |
| 132 | Postaxial foot polydactyly (HP:0001830) | 1.91199071 |
| 133 | Bile duct proliferation (HP:0001408) | 1.91184135 |
| 134 | Abnormal biliary tract physiology (HP:0012439) | 1.91184135 |
| 135 | Short tibia (HP:0005736) | 1.90999034 |
| 136 | Glomerulonephritis (HP:0000099) | 1.90093592 |
| 137 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.89432549 |
| 138 | Abnormality of the nasal mucosa (HP:0000433) | 1.89321147 |
| 139 | Large for gestational age (HP:0001520) | 1.87912297 |
| 140 | Morphological abnormality of the middle ear (HP:0008609) | 1.87766437 |
| 141 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.87620092 |
| 142 | Gingivitis (HP:0000230) | 1.87467680 |
| 143 | Conjugated hyperbilirubinemia (HP:0002908) | 1.86915307 |
| 144 | Back pain (HP:0003418) | 1.86835261 |
| 145 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.86360952 |
| 146 | Abolished electroretinogram (ERG) (HP:0000550) | 1.85912729 |
| 147 | Exotropia (HP:0000577) | 1.85478896 |
| 148 | Reticulocytosis (HP:0001923) | 1.84507203 |
| 149 | Obstructive lung disease (HP:0006536) | 1.84266712 |
| 150 | Chronic obstructive pulmonary disease (HP:0006510) | 1.84266712 |
| 151 | Abnormality of the ischium (HP:0003174) | 1.84118905 |
| 152 | Cerebellar dysplasia (HP:0007033) | 1.83591569 |
| 153 | Plantar hyperkeratosis (HP:0007556) | 1.83542497 |
| 154 | Hyperglycinemia (HP:0002154) | 1.83267406 |
| 155 | Fibular hypoplasia (HP:0003038) | 1.83191232 |
| 156 | Postaxial hand polydactyly (HP:0001162) | 1.82546264 |
| 157 | Labial hypoplasia (HP:0000066) | 1.82398453 |
| 158 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.82376238 |
| 159 | Vertebral hypoplasia (HP:0008417) | 1.82376238 |
| 160 | Megalencephaly (HP:0001355) | 1.82355581 |
| 161 | Abnormality of iron homeostasis (HP:0011031) | 1.82171892 |
| 162 | Disproportionate tall stature (HP:0001519) | 1.81815677 |
| 163 | Abnormal cartilage morphology (HP:0002763) | 1.81569388 |
| 164 | Vaginal atresia (HP:0000148) | 1.81534131 |
| 165 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.80705848 |
| 166 | Periodontitis (HP:0000704) | 1.80560806 |
| 167 | Bifid scrotum (HP:0000048) | 1.80144490 |
| 168 | Laryngomalacia (HP:0001601) | 1.79418468 |
| 169 | Long nose (HP:0003189) | 1.79089277 |
| 170 | Pustule (HP:0200039) | 1.78781880 |
| 171 | Cutaneous syndactyly (HP:0012725) | 1.78660568 |
| 172 | Hyperbilirubinemia (HP:0002904) | 1.78372301 |
| 173 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.78351835 |
| 174 | Joint swelling (HP:0001386) | 1.77926017 |
| 175 | Intestinal atresia (HP:0011100) | 1.77753940 |
| 176 | Polygenic inheritance (HP:0010982) | 1.76775164 |
| 177 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.76760296 |
| 178 | Synostosis involving the elbow (HP:0003938) | 1.76399041 |
| 179 | Humeroradial synostosis (HP:0003041) | 1.76399041 |
| 180 | Abnormality of the diencephalon (HP:0010662) | 1.76054090 |
| 181 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.75684611 |
| 182 | Cerebral palsy (HP:0100021) | 1.75669495 |
| 183 | Myositis (HP:0100614) | 1.75175666 |
| 184 | Hyperglycinuria (HP:0003108) | 1.74714094 |
| 185 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.73399307 |
| 186 | Hypoplastic iliac wings (HP:0002866) | 1.73145221 |
| 187 | Abnormal gallbladder physiology (HP:0012438) | 1.72400543 |
| 188 | Cholecystitis (HP:0001082) | 1.72400543 |
| 189 | Enlarged penis (HP:0000040) | 1.71971592 |
| 190 | Stenosis of the external auditory canal (HP:0000402) | 1.71824063 |
| 191 | Anophthalmia (HP:0000528) | 1.69264114 |
| 192 | Congenital hepatic fibrosis (HP:0002612) | 1.68971788 |
| 193 | Gait imbalance (HP:0002141) | 1.68929647 |
| 194 | Malnutrition (HP:0004395) | 1.66796255 |
| 195 | Lissencephaly (HP:0001339) | 1.66736559 |
| 196 | Congenital primary aphakia (HP:0007707) | 1.66631189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PKN2 | 5.08549475 |
| 2 | TRIB3 | 4.89389711 |
| 3 | KDR | 3.70135922 |
| 4 | ERN1 | 3.61283647 |
| 5 | CASK | 3.45035284 |
| 6 | PNCK | 3.29988010 |
| 7 | EPHB1 | 3.13213039 |
| 8 | BMPR1B | 2.95062200 |
| 9 | SIK1 | 2.85111227 |
| 10 | PTK6 | 2.66853412 |
| 11 | TNIK | 2.24879688 |
| 12 | MAPK15 | 2.24281523 |
| 13 | WNK3 | 2.24122847 |
| 14 | STK10 | 2.14803021 |
| 15 | ACVR1B | 2.13682300 |
| 16 | LRRK2 | 2.08748568 |
| 17 | TAOK3 | 2.05985655 |
| 18 | GRK1 | 1.88038836 |
| 19 | BLK | 1.86783172 |
| 20 | ADRBK2 | 1.86043560 |
| 21 | NTRK2 | 1.86030898 |
| 22 | IRAK4 | 1.83724174 |
| 23 | TBK1 | 1.73554245 |
| 24 | FGFR2 | 1.72234979 |
| 25 | FGFR4 | 1.71623822 |
| 26 | NTRK1 | 1.65251962 |
| 27 | EEF2K | 1.64253107 |
| 28 | WNK4 | 1.60485127 |
| 29 | PRKG2 | 1.60376902 |
| 30 | PINK1 | 1.58758068 |
| 31 | CSK | 1.55994804 |
| 32 | NUAK1 | 1.54934123 |
| 33 | BCR | 1.53125932 |
| 34 | STK39 | 1.52406967 |
| 35 | GRK6 | 1.48306481 |
| 36 | MAP4K2 | 1.43786698 |
| 37 | MARK1 | 1.43138740 |
| 38 | BMX | 1.43133211 |
| 39 | WEE1 | 1.42455871 |
| 40 | TYK2 | 1.35240633 |
| 41 | TTN | 1.34954291 |
| 42 | PTK2 | 1.34622641 |
| 43 | ZAK | 1.32212337 |
| 44 | MAP3K11 | 1.31317550 |
| 45 | STK38L | 1.31217515 |
| 46 | ALK | 1.29177470 |
| 47 | MKNK2 | 1.27868844 |
| 48 | PAK4 | 1.22252148 |
| 49 | BRSK2 | 1.19121179 |
| 50 | BCKDK | 1.15306108 |
| 51 | EPHA3 | 1.14551764 |
| 52 | FRK | 1.13204182 |
| 53 | TESK1 | 1.11149991 |
| 54 | MAP2K3 | 1.11115080 |
| 55 | ERBB2 | 1.09972183 |
| 56 | KSR2 | 1.09540942 |
| 57 | ERBB3 | 1.09161035 |
| 58 | MST1R | 1.09015740 |
| 59 | JAK1 | 1.06997784 |
| 60 | SIK2 | 1.05563409 |
| 61 | RIPK1 | 1.04638784 |
| 62 | TIE1 | 1.04050282 |
| 63 | PRKCE | 1.04030391 |
| 64 | TSSK6 | 1.04006354 |
| 65 | MAP3K4 | 1.03977769 |
| 66 | PLK2 | 1.02918313 |
| 67 | MAP3K8 | 0.99805331 |
| 68 | PLK4 | 0.98181719 |
| 69 | FES | 0.96836601 |
| 70 | MAP3K3 | 0.96512336 |
| 71 | JAK2 | 0.95202209 |
| 72 | MAPK13 | 0.94221188 |
| 73 | RET | 0.93226347 |
| 74 | TGFBR2 | 0.91257385 |
| 75 | BTK | 0.90702223 |
| 76 | CSNK1G2 | 0.86082691 |
| 77 | PRKCG | 0.85430571 |
| 78 | FLT3 | 0.84742755 |
| 79 | CAMK1G | 0.84049853 |
| 80 | MST4 | 0.83291573 |
| 81 | MAP4K1 | 0.83108675 |
| 82 | EPHA2 | 0.82101216 |
| 83 | ADRBK1 | 0.81557005 |
| 84 | PDGFRA | 0.80970708 |
| 85 | TAOK1 | 0.79946408 |
| 86 | OXSR1 | 0.78690213 |
| 87 | CDK6 | 0.77936699 |
| 88 | AKT3 | 0.77103283 |
| 89 | LIMK1 | 0.76075763 |
| 90 | CSNK1G1 | 0.75973806 |
| 91 | MAP3K10 | 0.75306790 |
| 92 | DAPK2 | 0.75101999 |
| 93 | INSRR | 0.74115436 |
| 94 | DYRK2 | 0.74050177 |
| 95 | PDPK1 | 0.73674785 |
| 96 | FGR | 0.73594720 |
| 97 | PIK3CG | 0.72036490 |
| 98 | NEK9 | 0.71900814 |
| 99 | MAP3K1 | 0.70534074 |
| 100 | ROCK1 | 0.69629042 |
| 101 | VRK1 | 0.67896758 |
| 102 | PTK2B | 0.67300823 |
| 103 | PRKAA2 | 0.66433580 |
| 104 | LATS1 | 0.66005318 |
| 105 | CDK3 | 0.65855240 |
| 106 | TRIM28 | 0.64695537 |
| 107 | MAPK4 | 0.64395170 |
| 108 | HCK | 0.64015796 |
| 109 | EPHA4 | 0.63767904 |
| 110 | IKBKE | 0.63676748 |
| 111 | STK3 | 0.62841038 |
| 112 | IRAK1 | 0.61743477 |
| 113 | ROCK2 | 0.61022410 |
| 114 | EGFR | 0.60251253 |
| 115 | PAK2 | 0.59378080 |
| 116 | MAPK11 | 0.58112077 |
| 117 | ZAP70 | 0.57743134 |
| 118 | MAP3K14 | 0.57259823 |
| 119 | PKN1 | 0.56468099 |
| 120 | FER | 0.56226087 |
| 121 | MAP2K1 | 0.56032489 |
| 122 | RPS6KB2 | 0.54914663 |
| 123 | PHKG2 | 0.54564221 |
| 124 | PHKG1 | 0.54564221 |
| 125 | SIK3 | 0.54462864 |
| 126 | MARK3 | 0.53625155 |
| 127 | PDK1 | 0.53356061 |
| 128 | CSNK1G3 | 0.53334902 |
| 129 | CSNK1A1L | 0.52641234 |
| 130 | JAK3 | 0.52200746 |
| 131 | IGF1R | 0.52059816 |
| 132 | CAMK1D | 0.51319582 |
| 133 | FGFR1 | 0.51056421 |
| 134 | LMTK2 | 0.50761812 |
| 135 | MET | 0.50720013 |
| 136 | NEK2 | 0.50279571 |
| 137 | MTOR | 0.50206854 |
| 138 | CDK12 | 0.49590766 |
| 139 | MAP2K4 | 0.49345202 |
| 140 | RIPK4 | 0.49344456 |
| 141 | EPHB2 | 0.49245592 |
| 142 | GSK3A | 0.48978228 |
| 143 | MAP2K2 | 0.48281873 |
| 144 | TESK2 | 0.47203619 |
| 145 | MKNK1 | 0.46293338 |
| 146 | SRC | 0.43961597 |
| 147 | ERBB4 | 0.42777292 |
| 148 | CAMK2A | 0.42561176 |
| 149 | NTRK3 | 0.42503675 |
| 150 | TGFBR1 | 0.42123271 |
| 151 | PLK3 | 0.41990097 |
| 152 | PAK3 | 0.41928640 |
| 153 | MAP3K2 | 0.41115175 |
| 154 | MAP2K7 | 0.40745064 |
| 155 | CLK1 | 0.39396114 |
| 156 | YES1 | 0.38604135 |
| 157 | CSNK1A1 | 0.38546055 |
| 158 | IRAK3 | 0.37600184 |
| 159 | PIM1 | 0.37494802 |
| 160 | MAP3K6 | 0.36107497 |
| 161 | CDK8 | 0.35742443 |
| 162 | MAP3K5 | 0.35309300 |
| 163 | TRPM7 | 0.35194087 |
| 164 | TEC | 0.35034805 |
| 165 | NEK1 | 0.34020951 |
| 166 | PRKCZ | 0.33898075 |
| 167 | PIK3CA | 0.33272649 |
| 168 | NLK | 0.31848582 |
| 169 | INSR | 0.31178618 |
| 170 | KSR1 | 0.27784882 |
| 171 | CSNK1D | 0.26432770 |
| 172 | SGK223 | 0.26024176 |
| 173 | SGK494 | 0.26024176 |
| 174 | SGK2 | 0.25878520 |
| 175 | CDK9 | 0.25309743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.48405616 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40970631 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.01024640 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96808946 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.95821335 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.61741365 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.38199162 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.30353060 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.29849287 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.28863122 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.22850635 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.14131070 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.13985203 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.12033661 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.09861461 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99577306 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97709443 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.89623144 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89006569 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87394564 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85863721 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.84619848 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.80816631 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80226518 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.76954566 |
| 26 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.59841077 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.57923068 |
| 28 | ABC transporters_Homo sapiens_hsa02010 | 1.50936614 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49587011 |
| 30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.48634172 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46270292 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.45884925 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45733556 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41480351 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.40154526 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39790733 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.39084237 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.38869116 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34290667 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33010946 |
| 41 | Protein export_Homo sapiens_hsa03060 | 1.29927695 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28360384 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.27164560 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.26378723 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 1.24445443 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23151237 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.20267406 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.19035729 |
| 49 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.18521060 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13575480 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11694510 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11252055 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09645412 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09444684 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09408510 |
| 56 | Nicotine addiction_Homo sapiens_hsa05033 | 1.08985217 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08639904 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06942027 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.05542696 |
| 60 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.04928312 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01711297 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00511038 |
| 63 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.98436087 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.97775846 |
| 65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97076051 |
| 66 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.96680582 |
| 67 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.96658835 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.95445930 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93704790 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.90945112 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90163373 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90043246 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88647464 |
| 74 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.87275749 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87036497 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86157941 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84032120 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83097172 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81097642 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77078021 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74728218 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.74553244 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73541813 |
| 84 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70490415 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65674384 |
| 86 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64481635 |
| 87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.64245069 |
| 88 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.63247495 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.62493308 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.62480917 |
| 91 | Asthma_Homo sapiens_hsa05310 | 0.61686296 |
| 92 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59415306 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58213404 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.53677593 |
| 95 | Taste transduction_Homo sapiens_hsa04742 | 0.53025634 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51633142 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51005068 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.50732426 |
| 99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49724878 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49447746 |
| 101 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49209888 |
| 102 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48723905 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47164168 |
| 104 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46945548 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46434567 |
| 106 | Insulin secretion_Homo sapiens_hsa04911 | 0.46321369 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45913423 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45452271 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44860995 |
| 110 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44610399 |
| 111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44551780 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44080095 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.44030368 |
| 114 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43678334 |
| 115 | Pertussis_Homo sapiens_hsa05133 | 0.42210874 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41278244 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41248588 |
| 118 | Morphine addiction_Homo sapiens_hsa05032 | 0.41108698 |
| 119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37716887 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37521993 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.36107595 |
| 122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35819316 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.35428723 |
| 124 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.35377077 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | 0.34825305 |
| 126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33948267 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33917108 |
| 128 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33578969 |
| 129 | Olfactory transduction_Homo sapiens_hsa04740 | 0.33575778 |
| 130 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33238873 |
| 131 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.33227539 |
| 132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32825746 |
| 133 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.32286645 |
| 134 | Phagosome_Homo sapiens_hsa04145 | 0.31610006 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31543492 |
| 136 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30833943 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.30486179 |
| 138 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30247778 |
| 139 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.29524751 |
| 140 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28380035 |
| 141 | Adherens junction_Homo sapiens_hsa04520 | 0.27563989 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24260207 |
| 143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.23482004 |
| 144 | Focal adhesion_Homo sapiens_hsa04510 | 0.23074739 |
| 145 | Tuberculosis_Homo sapiens_hsa05152 | 0.22986627 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.22865664 |
| 147 | Lysosome_Homo sapiens_hsa04142 | 0.21043162 |
| 148 | Influenza A_Homo sapiens_hsa05164 | 0.20926778 |
| 149 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18792680 |

